| 207 |
Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?
David K. GaffneyDavid K. Gaffney
KMSID: 1079006 J Gynecol Oncol. 2012;23(4):207-209. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.207 |
|
| 210 |
Emerging concept of tailored lymphadenectomy in endometrial cancerEmerging concept of tailored lymphadenectomy in endometrial cancer
Noriaki SakuragiNoriaki Sakuragi
KMSID: 1079007 J Gynecol Oncol. 2012;23(4):210-212. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.210 |
|
| 213 |
Combat against cervical cancer-challenges in Asia Oceania: 5th Biennial Conference of the Asia Oceania Research Organization on Genital Infections & Neoplasia (AOGIN)Combat against cervical cancer-challenges in Asia Oceania: 5th Biennial Conference of the Asia Oceania Research Organization on Genital Infections & Neoplasia (AOGIN)
Hextan YS NganHextan YS Ngan
KMSID: 1079008 J Gynecol Oncol. 2012;23(4):213-214. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.213 |
|
| 215 |
TGCS's Annual Meeting, August 10-12, 2012TGCS's Annual Meeting, August 10-12, 2012
Duangmani Thanapprapasr, Sarikapan WilailakDuangmani Thanapprapasr, Sarikapan Wilailak
KMSID: 1079009 J Gynecol Oncol. 2012;23(4):215-216. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.215 |
|
| 217 |
Early human papillomavirus testing predicts residual/recurrent disease after LEEPEarly human papillomavirus testing predicts residual/recurrent disease after LEEP
Aeli Ryu, Kyehyun Nam, Jeongja Kwak, Jeongsig Kim, Seob JeonAeli Ryu, Kyehyun Nam, Jeongja Kwak, Jeongsig Kim, Seob Jeon
KMSID: 1079010 J Gynecol Oncol. 2012;23(4):217-225. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.217 |
|
| 226 |
Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancerComparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer
Jeong-Yeol Park, Dae-Yeon Kim, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Young-Seok Kim, Ha Jeong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Seung Jae Huh, Joo-Hyun NamJeong-Yeol Park, Dae-Yeon Kim, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Young-Seok Kim, Ha Jeong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Seung Jae Huh, Joo-Hyun Nam
KMSID: 1079012 J Gynecol Oncol. 2012;23(4):226-234. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.226 |
|
| 235 |
Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancerComparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer
Tae Wook Kong, Suk-Joon Chang, Jiheum Paek, Seung-Chul Yoo, Jong-Hyuck Yoon, Ki-Hong Chang, Mison Chun, Hee-Sug RyuTae Wook Kong, Suk-Joon Chang, Jiheum Paek, Seung-Chul Yoo, Jong-Hyuck Yoon, Ki-Hong Chang, Mison Chun, Hee-Sug Ryu
KMSID: 1079013 J Gynecol Oncol. 2012;23(4):235-241. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.235 |
|
| 242 |
Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in KoreaPelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea
Heon Jong Yoo, Myong Cheol Lim, Sang-Soo Seo, Sokbom Kang, Chong Woo Yoo, Joo-Young Kim, Sang-Yoon ParkHeon Jong Yoo, Myong Cheol Lim, Sang-Soo Seo, Sokbom Kang, Chong Woo Yoo, Joo-Young Kim, Sang-Yoon Park
KMSID: 1079014 J Gynecol Oncol. 2012;23(4):242-250. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.242 |
|
| 251 |
How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter studyHow low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter study
Sokbom Kang, Jong-Min Lee, Jae-Kwan Lee, Jae Weon Kim, Chi-Heum Cho, Seok-Mo Kim, Sang-Yoon Park, Chan-Yong Park, Ki-Tae KimSokbom Kang, Jong-Min Lee, Jae-Kwan Lee, Jae Weon Kim, Chi-Heum Cho, Seok-Mo Kim, Sang-Yoon Park, Chan-Yong Park, Ki-Tae Kim
KMSID: 1079015 J Gynecol Oncol. 2012;23(4):251-256. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.251 |
|
| 257 |
Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinomaRisk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma
Agnes Y. Bahng, Christina Chu, Paul Wileyto, Stephen Rubin, Lilie L. LinAgnes Y. Bahng, Christina Chu, Paul Wileyto, Stephen Rubin, Lilie L. Lin
KMSID: 1079016 J Gynecol Oncol. 2012;23(4):257-264. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.257 |
|
| 265 |
Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancerPlatelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer
Supachai Raungkaewmanee, Siriwan Tangjitgamol, Sumonmal Manusirivithaya, Sunamchok Srijaipracharoen, Thaovalai ThavaramaraSupachai Raungkaewmanee, Siriwan Tangjitgamol, Sumonmal Manusirivithaya, Sunamchok Srijaipracharoen, Thaovalai Thavaramara
KMSID: 1079017 J Gynecol Oncol. 2012;23(4):265-273. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.265 |
|
| 274 |
Overexpression of CD73 in epithelial ovarian carcinoma is associated with better prognosis, lower stage, better differentiation and lower regulatory T cell infiltrationOverexpression of CD73 in epithelial ovarian carcinoma is associated with better prognosis, lower stage, better differentiation and lower regulatory T cell infiltration
Hoon Kyu Oh, Jeong-Im Sin, Junghae Choi, Sung Hae Park, Tae Sung Lee, Youn Seok ChoiHoon Kyu Oh, Jeong-Im Sin, Junghae Choi, Sung Hae Park, Tae Sung Lee, Youn Seok Choi
KMSID: 1079018 J Gynecol Oncol. 2012;23(4):274-281. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.274 |
|
| 282 |
New insights into cervical cancer screeningNew insights into cervical cancer screening
Jonathan D. Boone, Britt K. Erickson, Warner K. HuhJonathan D. Boone, Britt K. Erickson, Warner K. Huh
KMSID: 1079020 J Gynecol Oncol. 2012;23(4):282-287. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.282 |
|
| 288 |
Sweet's syndrome: a cutaneous harbinger of ovarian carcinomaSweet's syndrome: a cutaneous harbinger of ovarian carcinoma
Amanda Nickles Fader, Abigail Duncan Winder, Samith Sandadi, Robert DeBernardoAmanda Nickles Fader, Abigail Duncan Winder, Samith Sandadi, Robert DeBernardo
KMSID: 1079021 J Gynecol Oncol. 2012;23(4):288-290. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.288 |
|
| 291 |
Book Review: The emperor of all maladies: a biography of cancerBook Review: The emperor of all maladies: a biography of cancer
Dong Hoon SuhDong Hoon Suh
KMSID: 1079022 J Gynecol Oncol. 2012;23(4):291-292. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.291 |
|
| 293 |
Journal correction: Radiation therapy with chemotherapy for patients with cervical cancer and supraclavicular lymph node involvementJournal correction: Radiation therapy with chemotherapy for patients with cervical cancer and supraclavicular lymph node involvement
KMSID: 1079023 J Gynecol Oncol. 2012;23(4):293-293. Published online 2012 September 19 DOI: http://dx.doi.org/10.3802/jgo.2012.23.4.293 |
|
